Brentwood, Tenn.-January 21, 2009-Praxis, a company specializing in centralized patient recruitment for clinical research studies, recently provided patient recruitment services to a major pharmaceutical company for a study to test an investigational medication for a women’s health indication. The recruitment program saved 10 months off the enrollment period and delivered a 450% return on investment for the sponsor. Praxis’ centralized recruitment program directly delivered 62% of all patients randomized into the study.
This was the second in a branded series of studies for this indication. Through Praxis’ analysis of metrics and data, a customized marketing strategy and extension of the brand campaign was developed to successfully motivate women to respond. “The need for branded continuum campaigns is something Praxis has been on the leading edge of. When executed successfully, this approach adds a whole new level of success for our sponsor partners and in the end that is our ultimate goal.” say David Fox, Praxis President & CEO. Additionally, Praxis launched a comprehensive retention campaign to encourage study compliance and completion by each subject. This resulted in an 85% retention rate, which is 21% greater than the industry average for phase II studies.
The study was centrally managed and patient recruitment results were available in real-time, 24/7 using PraxisDirect®, Praxis’ online study management technology. The real-time analysis of PraxisDirect also allowed for effective allocation of media dollars. In comparing this study to its predecessor, the response rates were 12% higher. This insight allowed Praxis to invest more media dollars in site areas where the campaign was receiving high returns. The PraxisDirect technology also played a key role in the daily life of the study coordinator by offering key assistance and tracking regarding patient outcomes. Study Coordinator Holly Jarrell says “I have worked with several central recruiting agencies over the past few years and I can say without hesitation that Praxis was definitely the best. We received so many referrals from your central ad campaign and that is very uncommon on most studies using central advertising that I have dealt with in the past. You guys really did your research on advertising in our area and it really showed.” The system is consistently rated excellent by study coordinators in terms of ease of use and content.
Praxis Communications, Inc., headquartered in Brentwood, Tenn., provides the pharmaceutical and biotech industries with a wide range of global services for patient recruitment and retention for clinical trials including patient profiling, recruitment planning, centralized fulfillment, media relations, advertising, and program management. For more information, call Praxis at (615) 312-8207 or visit
www.GoPraxis.com
.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.